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Abstract
This thesis is concerned with a new class of drugs known as synthetic
cathinones which overruns the drug markets in recent years as “legal highs” drugs,
under different commercial names such as bath salts. All synthetic cathinone
derivatives consist of a chiral center and usually sold out as a racemic mixture. Usually,
one of the two enantiomers will have stronger central nervous system (CNS)
stimulatory activity and the other one may have no significant CNS activity or
addictive properties. A new sensitive and selective analytical method was developed
for the simultaneous determination of ten synthetic cathinones enantiomers in spiked
urine samples by gas chromatography coupled with tandem mass spectrometry GCNCI-MS/MS. Multiple reaction monitoring (MRM) mode was used for synthetic
cathinones enantiomers identification and quantification in the presence of 3-MMC as
an internal standard. The method adopted the indirect chiral separation of the synthetic
cathinones enantiomers using menthylchloroformate (MCF) as the chiral derivatizing
agent (CDA).
Solid phase extraction (SPE) was used for urine samples clean up followed by
derivatization step using MCF prior to gas chromatography analysis. The developed
method was validated in terms of linearity, sensitivity, intraday and interday
reproducibility, and recovery for all tested spiked urine samples. The method showed
linearity and good correlation coefficient (R2) values higher than 0.98 within the tested
range of 0.5 to 50 ppm for all synthetic cathinones enantiomers spiked in urine. The
limits of quantitation in urine was 0.012 – 9.536 ppm and for limits of detection was
0.004 – 3.147 ppm. For reproducibility, the mean value of coefficient of variance was
below 12.3%. The mean recovery error was below 12%.
The developed method can be used in forensic laboratories for separation and
quantitative determination of synthetic cathinones enantiomers in urine samples. The
separated and quantified enantiomers can provide information regarding the sources
of these drugs and the raw materials used to create them to help law enforcement
agencies with the drug tracking.

Keywords: Synthetic cathinones, enantiomers, derivatization, chiral separation,
menthylchloroformate, gas chromatography, tandem mass spectrometry (MS/MS).
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)Title and Abstract (in Arabic

تطوير طريقة تحليل جديدة لفصل وتحديد كميات التحضيرات الصناعية لمركبات
الكاثينون المصنعة في البول باستخدام جهاز الفصل الغازي ومطياف الكتل
الملخص

تختص هذه األطروحة بنوع جديد من العقاقير المعروفة بمركبات الكاثينون المصنعة
) (Synthetic Cathinonesالتي تعد طفرة جديدة في سوق المخدرات والعالم حيث تأخذ
مسميات تجارية مختلفة مثل "أمالح االستحمام" ) .(Bath saltsتحتوي جميع مركبات الكاثينون
المصنعة على مركز انطباقي ) (Chiral centerحيث إنها تصنع وتنشر في األسواق على شكل
مزيج راسيمي ) .(Racemic mixtureتشكل إحدى المقابالت الضوئية ) (Enantiomersفي
مركبات الكاثينون المصنعة وكغيرها من المركبات التي تحتوي على مركز انطباقي ،لها تأثير
أكبر على نظام األعصاب المركزي البشري من المقابالت الضوئية األخرى .تم تطوير وسيلة
تحليلية للفصل االنطباقي والتحليل الكمي لعدد عشر من مركبات الكاثينون المصنعة ومقابالتها
الضوئية في البول باستخدام جهاز الفصل الغازي ومطياف الكتل ) .(GC-MSتم التحقق من
صحة وكفاءة طريقة التحليل المتبعة من خالل تقدير الخطية ) (linearityوتقدير حساسية الطريقة
) (sensitivityومعدل االستعادة ) (reproducibilityومعدل االسترجاع ).(recoveries
تتبنى هذه الوسيلة طريقة الفصل االنطباقي غير المباشر للمقابالت الضوئية لمركبات الكاثينون
المصنعة باستخدام مركب ).(Menthylchloroformate
من اهم النتائج المتحصل عليها نسبة الخطية لجميع المقابالت الضوئية لمركبات الكاثينون في
معدل التراكيز  0.5 – 50مليجرام  /لتر في البول .كان معدل الحد الكمي 0.012 – 9.536
مليجرام  /لتر ومعدل نسبة حد الكشف االدنى  0.004 – 3.147مليجرام  /لتر .تم قياس إمكانية
التكرارية من نسبة فرق التباين وكانت النسبة اقل من  12.3%وتم قياس نسبة االسترجاع بنسبة
الخطأ وكانت أقل من .12%
يمكن استخدام هذه الوسيلة التحليلية من قبل المختبرات الجنائية في فحص المقابالت الضوئية
لمركبات الكاثينون المصنعة في البول لتوفير المعلومات الكافية حول مصدر هذه المخدرات
والمواد الخام المستخدمة فيها ومكان تصنيعها وذلك لمساعدة رجال األمن في تتبع وتحديد مصدها.
مفاهيم البحث الرئيسية :مركبات الكاثينون المصنعة ،المقابالت الضوئية ،الفصل االنطباقي،
الفصل الغازي ،مطياف الكتل ،اشتقاق.
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Chapter 1: Introduction
1.1 Overview
Catha edulis, or Khat, is the name of a flowering shrub grown mainly in some
parts of Africa and the Arabian Peninsula. Khat chewing plays a dominant role in
everyday life style in some countries such as Yemen especially among men, where
they consume it in social celebrations, and political meetings (Luqman, 1976). Khat is
commonly chewed when fresh and sometimes it is left to dry and then consumed as
stimulating beverage (Mwenda et al., 2004). Khat belongs to the Celastraceae family
(the bitter-sweet family of plants) and it has different vernacular names based on its
origin: Khat (or Qat) in English and in Arabic used in Yemen, and Jimaa or Chat in
Ethiopia (Lemessa and Ababa, 2001).
Many chemical studies on the components of Catha edulis showed that khat
leaves consist of different chemicals such as: alkaloids, essential oils, amino acids,
proteins, traces of vitamin C and iron (Al-hebshi and Skaug, 2005). The psychostimulating properties of the khat is mainly caused by the presence of alkaloids. There
are two major classes of alkaloids present in khat, the phenylalkylamines and the
complex polyesters of polyhydroxylated dihydroagarofurans (cathedulins) (Crombie
et al., 1990). Among the different classes of alkaloids in khat, (-) Cathinone is
considered to be the most pharmacologically active component in khat leaves. (-)
Cathinone belongs to the phenylalkylamines class of alkaloids found in khat and it was
identified in late 20th century (Widler et al., 1994). It was found that cathinone is
present with high concentration in young fresh leaves and its concentration vary (0.93.3%) according to the origin of the khat tree. The active compound is very fragile and
its concentration declines within few days after harvesting (Patel, 2009). The post
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harvesting degradation of (-) Cathinone is mainly caused by sunlight exposure and
heat. This degradation process of (-) Cathinone results in new less active compounds,
which explains the need to chew fresh khat leaves immediately after harvesting
(Valente et al., 2014).
Cathinone, the psychoactive phenylalkylamines class of alkaloids found in
khat has an amphetamine-like structure and stimulant effects. Amphetamine is a wellknown classical drug of abuse worldwide. Therefore, cathinone is considered to be a
natural beta-keto amphetamine analogue found in the leaves of khat plant (Albals et
al., 2016). Scheme 1 shows the chemical structure of cathinone and amphetamine.

Scheme 1: Chemical Structure of Cathinone and Amphetamine
Recent studies reported that khat is used by more than five million people every
day, despite the variation among countries regarding the legality of the khat plant. The
UN Convention on Psychotropic Substances in 1988, banned Cathinone, the natural
stimulant found in khat, and it was listed as a Schedule I substance. Few authorities
around the world are not familiar with khat and how to react to it in terms of
categorization: should khat be treated as a drug, such as heroin and cannabis or be
treated as tobacco and coffee? (Lamina, 2010). There are many reports on the health
effects of khat-chewing such as malnutrition, liver cirrhosis, insomnia, pulmonary
edema and other serious health effects (Al-hebshi and Skaug, 2005). Due to the
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harmful effects of khat, many countries have treated khat as a controlled substance,
including the United Arab Emirates, since 1995.
Traditionally, the main psychoactive component of khat plant, cathinone is
extracted during the chewing process of the fresh green leaves of khat. On the other
hand, a new generation of modified cathinones have been synthesized and abused in
different regions around the world known as New Designer Drugs (NDD) or Novel
Psychoactive Drugs (NPD). This new strategy taken by drug dealers to sell their
products as “novel psychoactive substances,” which contain at least one chemical
substance that has similar biological effects as of the illegal natural cathinone allow
them to offer legal alternative to the controlled substance. Those modified or
synthesized cathinones are considered as “legal highs’ and usually labeled as “not for
human consumption” under the name of “bath salts” and other commercial names to
circumvent drug abuse legislation and to become widely spread. Synthetic cathinones
or bath salts as known in the United States are mostly sold over the internet and in
head shops as white powder, crystalline mixture or tablets. These compounds are
usually snorted, smoked, injected intravenously or taken orally (German et al., 2014).
Mephedrone (4-methylmethcathinone) is the first synthesized cathinone, became one
of the most popular abused drugs in Europe since 2007 (Dargan et al., 2011). This
cathinone derivative has produced many serious intoxications and some deaths in
different countries. Due to the high concerns about the abuse of the cathinone-related
derivatives and other novel psychoactive substances in Europe, the UK government
and European Monitoring Center for Drugs and Drug Addiction (EMCDDA) banned
all cathinone derivatives in April 2010 (Alremeithi et al., 2018).
Most of the known synthetic cathinones have been derived from
Methcathinone (Scheme 2), which had been developed in the former Soviet Union as
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antidepressant in the 1930s and soon after around 1950s separately developed in the
West as an appetite suppressant. The developed compound was never marketed due to
its adverse reaction on human biological system and addictive potential (Spiller et al.,
2011). Nowadays, methcathinone is synthesized using over-the-counter drugs as
precursor such as ephedrine and pseudoephedrine, followed by other reactions to
produce other synthetic cathinones or methcathinone derivatives (Sikk and Taba,
2015).
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Scheme 2: Chemical Structures of Synthetic Cathinones Derived from
Methcathinone
(Katz et al., 2014)
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Only in the early 21st century, the abuse of synthetic cathinones has been
reported in different regions around the world, even though the first synthetic
cathinone was developed 30 years before. This rise is fueled by the decrease in
availability, purity, regulations, and high cost of other stimulant drugs of abuse,
including 3,4-methylenedioxy-N-methylamphetamine (MDMA) and cocaine. The US
and European drugs enforcement agencies indicate that the recent synthetic cathinone
abuse involves mostly Methylenedioxypyrovalerone (MDPV) and Mephedrone, with
less often implication with methylone, flephedrone, and naphydrone (Capriola, 2013).
In 2009, in the UK, high percentage of night club attendees reported lifetime synthetic
cathinones use especially mephedrone. Between August 2009 and August 2010 in
Finland, 6% of 259 cases of driving under the influence were tested positive for
MDPV. Moreover, about 2,656 calls have been received in 2012 by the American
Poison Control Centers regarding exposure to synthetic cathinones, mainly in age
group between 20 and 30-year old. Synthetic cathinones abuse resulted in interaction
with law enforcement, emergency units’ engagement and implicated many users in
critical conditions that can lead to death (Concheiro et al., 2013).
Like amphetamine, cocaine and other stimulation-induced drugs, synthetic
cathinones stimulate the central nervous system (CNS) by increasing synaptic
concentration of serotonin, dopamine and norepinephrine. This increase of different
neurotransmitters in CNS results in desired effects such as: increase in energy,
sociability, and sexual desire. On the other hand, undesired effects such as: insomnia,
increase heart rate, confusion, dizziness, prolonged panic attack and suicidal thoughts
have been reported by users (Coppola and Mondola, 2012).
Despite the fact that many of the existing synthetic cathinones have been
already scheduled, clandestine laboratories constantly synthesizing new synthetic
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cathinone derivatives to replace the outlawed new designed drugs as soon as legislation
passes (German et al., 2014). In order to win this cat-and-mouse game between the
law makers and clandestine laboratories, focused studies must be undertaken to
investigate the neuropharmacology properties of these substances to prevent the abuse
risks of novel psychoactive substances and help the law enforcement with the drug
tracking.
1.2 Statement of the Problem
In recent years, synthetic cathinones have spread across many regions around
the world as an important class of the new designer drugs (NDD). This proliferation
of synthetic cathinones has been associated with multiple criminal acts, intoxications
and fatalities. From a forensic standpoint, this proliferation makes scientists in an
ongoing challenge to develop new analytical methods for synthetic cathinones
detection to keep up with the high pace of NDD trends.
All synthetic cathinone derivatives consist of a chiral center and usually sold
out as a racemic mixture. Usually, one of the two enantiomers will have stronger
central nervous system (CNS) stimulatory activity and the other one may have no
significant CNS activity or addictive properties (Mohr et al., 2012). Therefore, it is
important to develop an analytical method capable of separating and detecting the
synthetic cathinone enantiomers to provide information regarding the sources of these
drugs and the raw materials used to create them to help law enforcement agencies with
the drug tracking.
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1.3 Objectives of the Study
General Objective
The general objective of this study was to develop and validate a sensitive and
selective analytical method for qualitative and quantitative determination of synthetic
cathinones enantiomers in spiked urine samples
Specific Objectives
1. To develop and validate a new enantioseparation method for synthetic
cathinones in urine using Gas Chromatography-Tandem Mass Spectrometry
(GC-MS/MS) with Negative Chemical Ionization (NCI) and Multiple Reaction
Monitoring (MRM) mode.
2. To test the feasibility of Menthylchloroformat (MCF) as derivatizing agent and
its effect on the selectivity and sensitivity of the method.
1.4 Approach
This study involves the following tasks:
Task 1: Developing the Gas Chromatography (GC) separation method for synthetic
cathinones.
Task 2: Developing the Mass Spectrometry (MS) detection of synthetic cathinones
using Multiple Reaction Monitoring (MRM) mode.
Task 3: Optimizing the GC-NCI-MSMS with the most suitable reagent gas.
Task 4: Work with spiked urine samples, optimize sample preparation, cleanup and
derivatization.
Task 5: Method validation.

9
1.5 Relevant Literature
1.5.1 Synthetic Cathinones and Chiral Compounds
Chirality (also called enantiomers, dissymmetry or stereoisomerism) is a term
used to describe objects that are mirror image of each other and therefore they cannot
be superimposed. The origin of chiral term comes from the Greek word cheir, which
means “handedness”. In chemistry, a molecule is called chiral when its mirror-image
cannot be superimposed, and the two non-superimposed forms of chiral molecules are
described as enantiomers. Looking at the human hands as an example, left and right
hands are mirror-image or enantiomers. Enantiomers are usually formed when an atom
like Carbon (Also Sulfur, Nitrogen and Phosphorus) that can act as an asymmetric
center and contains four different substituents. The two enantiomers of a chiral
compound can be classified as Dextrorotary (D-isomer) and Levorotary (L-isomer) or
Rectus (R-isomer) and Sinister (S-isomer) based on their ability to rotate planepolarized light. Racemic mixture or “Racemate” refers to a mixture that has same
concentration of the two enantiomers of a chiral compound. Even though the two
enantiomers of a chiral compound may have similar chemical and physical properties,
their biological activities usually vary (Nguyen et al., 2006).
1.5.2 Chiral Compounds Separation
Scientists in different fields have been recognizing the importance of chirality
and enantioseparation of chiral compounds with respect to biological systems. Since
our physiological environment is chiral, any two enantiomeric forms of a chiral
compound may differ dramatically in their biological activities.
There are two main approaches used within the pharmaceutical studies to
separate chiral compounds: A direct method, where the enantiomers are separated
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inside a column that has a chiral stationary phase (CSP) or as a chiral selector in a
mobile phase with an achiral stationary phase. The other approach is based on the
formation of two corresponding enantiomers by reacting the chiral compounds with
chiral derivatizing agent (CDA) and separating them on an achiral stationary phase
(Ilisz et al., 2008). The low cost, commercial availability of CDA and easier method
development make the indirect approach an efficient technique for the
enantioseparation of chiral compounds. Table 1 lists the advantages and disadvantages
of both indirect and direct method.
Table 1: Comparison of advantages and disadvantages of indirect and direct method
(Ilisz et al., 2008)
Indirect method

Direct method

Advantages:
1. Good chromatographic properties
of derivatives
2. Predictable elution sequence
3. Good fluorophoric or
chromophoric properties of the
reagent
4. Low cost of achiral column
5. Simple method development
6. High selectivity

1. The purity of the chiral selector is
not critical
2. Similar molar absorptivities of
enantiomers
3. Absence of racemization
4. Simple preparation of analyte
5. Temperature changes favorable
6. Availability of preparative
applications

Disadvantages:
1. The purity of the CDA is critical
2. The molar absorptivity of the two
enantiomers may differ
3. Possibility of racemization
4. Possibility of interferences
5. Derivatization process may be
time-consuming

1. Small theoretical plate number for
CSP
2. Slow kinetics of desorption
3. No universal column exists
4. Possibility of interferences
5. CSPs are sensitive to
chromatographic condition
6. High cost of chiral columns
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1.5.2.1 Direct Chiral Separation
In recent years, the method of direct chiral separation without the prior step of
derivatization has gotten more attention from the analytical scientists. The direct
method avoids the downside of the indirect method (Table 1), and usually simple and
quicker in terms of sample preparation and analysis (Mehta, 1988). From the recently
published papers, High performance liquid chromatography (HPLC) and Capillary
electrophoresis (CE) are the two most used techniques for the direct chiral separation
(Ward and Ward, 2010). These two techniques use chiral stationary phases (CSPs)
such polysaccharide CSPs, ligand exchange CSPs, protein bound CSPs and cavity
CSPs as chiral selectors (Sekhon, 2010).
High performance liquid chromatography (HPLC) is the most preferred
method of direct chiral separation, and often uses polysaccharide CSPs. Although
polysaccharide-based CSPs is the dominant and most used CSPs, macrocyclic and
cyclodextrin-based CSPs applications are earning high attention lately (Ward and
Ward, 2010). Designing and developing chiral stationary phases capable of efficient
chiral recognition and separation is a key point of chiral chromatographic techniques.
There are more than 100 CSPs have been prepared and commercialized for HPLC and
other separation techniques (Yashima, 2001). In addition to the CSPs, other
experimental variables such as ionic strength, pH, mobile phase (MP), buffer type, etc.
may affect the chiral separation on HPLC (Ismail et al., 2018). Table 2 shows recent
publications used HPLC for direct chiral separation.
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Table 2: Recent publications used high performance liquid chromatography (HPLC)
for direct chiral separation
Targets

Samples

CSPs

Reference

8 Anticholinergic drugs

Standards
(Racemic)

Polysaccharide

(Li et al., 2018)

8 Bedaquiline analogue

Standards
(Racemic)

Polysaccharide

(Jiang et al.,
2019)

Miconazole

Standard
(Racemic)
Salt

Polysaccharide

(Bounoua et al.,
2018)
(Ismail et al.,
2018)

Quinolones

Standard
(Racemic)

(Ali et al.,
2018)

Propranolol, Atenolol,
Metoprolol, Venlafaxine,
Fluoxetine, and
Amlodipine

Standards
(Racemic)

Teicoplanin
Macrocyclic
glycopeptide
Vancomycin

18 Synthetic Cathinones

Urine and
Plasma

Astec Cellulose DMP
and Amylose-based
Chiralpak AS-H

(Meetani et al.,
2019)

12 Isoxazolines
Racemate

Standards
(Racemic)

Pherphenylcarbamate
cyclodextrin (CD)

(Yang et al.,
2017)

22 Basic Pharmaceutical
Drugs

Standards
(Racemic)

Vancomycin

(Guo et al.,
2018)

Substituted 1,3diazaspiro[4.5]decan-4ones

Standard
(Racemic)

Polysaccharides

(Aboul-Enein et
al., 2018)

Active Pharmaceutical
Ingredient (API)

Macrocyclic
glycopeptide

(Li et al., 2019)
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Besides HPLC, CE has attracted the attention of many analytical chemists who
work in the field of enantioseparation in recent years. CE separation is a microscale
technique capable of separating chiral ionic compounds, such as amino acids. CE
selectivity is based on the compound charge to size ratio (Prior et al., 2016). One of
the most common CSP or chiral selector used for chiral CE is Cyclodextrins (CDs)
such as β-Cyclodextrin (β-CD) Scheme 3. The differential interaction between the two
enantiomers of a chiral compound with the chiral selector, such as CDs, causes
differences in their overall electrophoretic migration resulting in their separation
(Gübitz and Schmid, 2004). Table 3 shows recent publications used CE for direct
chiral separation.

Scheme 3: Chemical Structure of Cyclodextrin
(Stick and Williams, 2009)
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Table 3: Recent publications used Capillary Electrophoresis (CE) for direct chiral
separation
Targets

Samples

CSPs

Reference

Tramadol (TRA)
and Methadone
(MET)

Tablets, Urine,
and Plasma

Maltodextrin

(Naghdi and
Fakhari, 2018)

5 Acidic Drugs

Raw material
(Racemic
samples)

Streptomycin

(Zhang et al.,
2017)

Terbutaline and
non-steroidal antiinflammatory drugs
Novel Psychoactive
Substance (NPS)

Raw material
(Racemic
samples)
Standards
(Racemic)

Lysine-Bridged
Hemispherodextrin

(Cucinotta et al.,
2017)

(+) ‐18‐crown‐6‐
tetracarboxylic acid

(Hägele and
Schmid, 2018)

Amphetamines and
Ephedrine

Seized material

Highly sulfated‐γ‐
cyclodextrin (HS‐γ‐
CD)

(Cui et al., 2018)

Cetirizine

Standard
(Racemic)

Dual Selector system: (Švecová and
Borate-glucose
Petr, 2019)
complexes and
Sulfated-βcyclodextrin (S- β
CD)

Anti-Alzheimer and Standards
Antifungal drugs
(Racemic)

Several modified
cyclodextrin (CD):
Highly sulfated α, γ
CDs, hydroxyl
propyl‐β‐CD, and
Sulfobutyl ether‐β‐
CD

(Abdel-Megied et
al., 2018)

Non-protein amino
acid homocysteine

Standard
(Racemic)

Cyclodextrins (α -β γ‐CD)

(Greño et al.,
2018)

3 Synthetic
Cathinones

Standards
(Racemic
mixtures)
Standard
(Racemic)

2-hydroxyethyl-βcyclodextrin

(Nowak et al.,
2018)

Sulfobutylether‐β‐
cyclodextrin

(Szabó et al.,
2019)

Rasagiline
(Antiparkinsonian
drug)
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1.5.2.2 Indirect Chiral Separation
Enantioseparation of chiral compounds can be obtained by the indirect method
using chiral derivatizing agent (CDA). Both the targeted chiral compound and CDA
must have compatible and derivatizable functional groups in order to undergo the
reaction and form two possible diastereisomers which can be separated using an achiral
column (Ilisz et al., 2008). For example, the primary and secondary amines synthetic
cathinones have a compatible site for derivatization with CDA by the removal of one
acidic hydrogen of amine and formation of a new amide bond between the chiral
compound and CDA. On the other hand, tertiary amines synthetic cathinones cannot
be derivatized using the indirect method since they lack compatible sites for CDA. The
resulted diastereisomers from the reaction of a chiral compound with CDA will interact
differently with the achiral stationary phase (or column) and show at different retention
times when using separation technique such as Gas Chromatography (GC) or Liquid
Chromatography (LC).
Despite, the development of selective chiral chromatographic columns for
chiral separation, many scientists prefer the use of CDA in GC and other separation
techniques. The reasons are the availability and low cost of most of the CDA and the
ability to use an achiral column to produce high resolution separation of the two
corresponding enantiomers.
1.5.3 Cathinones Chiral Separation using Gas Chromatography
Gas chromatography (GC) hyphenated with mass spectrometry (MS) is one of
the analytical technique used for chiral separations of synthetic cathinones (Alremeithi
et al., 2018). GC-MS can perform direct and indirect chiral separation. The direct
approach mainly performed on chiral stationary phase (CSPs) or column as a selector.
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The indirect approach requires derivatization of the chiral compound using chiral
derivatizing agents (CDA), then the resulted diastereisomers are separated on an
achiral stationary phase or column (Camacho-Munoz et al., 2016).
There are many commercially available derivatization agents used for the
derivatization of alkaloids and amphetamine-like drugs using GC-MS such as (S)-(-)N-(Trifluoroacetyl)pyrrolidine-2-carbonyl chloride (L-TPC), see Scheme 4, (Weiß et
al., 2015).

Scheme 4: Chemical Structures of L-TPC and FLEC
Alremeithi et al. recently reported an indirect chiral separation of thirty-six
synthetic cathinone compounds using L-TPC as the chiral derivatizing agent in GCMS (Alremeithi et al., 2018).
(±)-1-(9-fluorenyl)ethyl chloroformate (FLEC), see Scheme 4, is another wellknown CDA, used in for chiral separation of environmental and pharmaceutical
relevant molecules (Moldovan et al., 2017). FLEC chiral derivatizing agent was used
for separation and quantitative determination of β -Methylamino-L-alanine (BMAA)
enantiomers. Derivatization of BMAA with FLEC prior to LC-MS/MS injection
resulted in high resolution separation of D- and L- BMAA derivatives (Zurita et al.,
2019).
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Another CDA called (1R)-(-)-menthylchloroformate (MCF) was used to
achive chiral separation of many chiral compounds. MCF is consider cheap and readily
available chiral derivatizing agent (Přech et al., 2013). The use of MCF as CDA for
indirect chiral separation of novel amphetamine derivatives by GC-MS was reported
recently (Weiß et al., 2017). The article compared menthylchloroformate with another
CDA called (R)-(+)- α-methoxy- α-trifluoromethylphenylacetic acid (MTPA) and it
was reported that menthylchloroformate was feasible to chirally separate few of the
amphetamine derivatives, but with less satisfying resolution compared to MTPA.
Scheme 5 shows the chemical structure of menthylchloroformate (MCF).

Scheme 5: Chemical Structure of Menthylchloroformate (MCF)
Menthylchloroformate (MCF) was used as CDA for rapid and simple chiral
separation of natural and synthetic origin substituted Tetrahydroisoquinolines
(THIQs). The developed method proved robustness where all THIQs diastereoisomers
easily resolved with high resolution using achiral GC column (Přech et al., 2013).
The use of menthylchloroformate (MCF) as CDA for chiral separation of
synthetic cathinones using GC-MS or any other separation techniques is yet to be
reported. Table 4 shows publications for indirect chiral separation using chiral
derivatizing agents (CDAs).
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Table 4: Indirect chiral separation using chiral derivatizing agents (CDAs)
Targets

Samples

CDA

Instrument

Reference

Ketoprofen (KET)

Saliva

(S)-1-methyl-4-(5-(3aminopyrrolidin-1yl)-2,4-dinitrophenyl) piperazine
(APy-PPZ)

LC-MS/MS

(Jin et al.,
2018)

Methamphetamine

Human
Marfey’s reagent (Noral fluids (2,4-dinitro-5fluorophenyl)-Lalaninamide)

LC-MS/MS

(Borg et
al., 2018)

Pregabalin

Standard
(S)
(Racemic) trifluoroacetylprolyl
chloride ((s)-TPC)

GC-MS

(Hitchcoc
k and
Marginean
, 2018)

31 Synthetic
Cathinones

Human
urine and
plasma

(S)-()-NGC-MS
(trifluoroacetyl)pyrrol
idine-2-carbonyl
chloride (L-TPC)

(Alremeit
hi et al.,
2016)

1.5.4 Quantitative Analysis of Synthetic Cathinones
In forensic toxicology, it is important to perform qualitative and quantitative
analysis to identify the type of illicit drug an abuser consumed and how much of it is
presented in his or her biological samples such as blood or urine at the time of arrest.
The quantitative analysis plays a major role in courts and law as it can determine the
penalty for the abuser. In postmortem toxicology, quantitative analysis can provide
information regarding the cause of death.
In recent years, many qualitative and quantitative methods were developed by
scientists using different analytical approaches. On the other hand, New Designer
Drugs (NDD) such as synthetic cathinones have taken great attention from the
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scientific community and forensic science due to their toxicity and rapid growth
around the world. Unfortunately, many forensic laboratories do not have a
comprehensive analytical screening method available for detection and quantitative
determination of NDD in biological samples. The rapid growth and emerging of these
types of drugs forces the forensic laboratory to continually modify their existing
screening methods (Zuba and Adamowicz, 2018).
Several analytical methods have been developed for the quantitative
determination of synthetic cathinones in biological samples such as urine, blood and
hair using gas chromatography coupled with mass spectrometry (GC-MS) or coupled
with other detectors. On the other hand, there is a shortage in studies focusing on the
quantitation of enantiomers of chiral drugs such as synthetic cathinones. In this thesis,
a chiral quantitation method will be developed for synthetic cathinones determination
in spiked urine samples after dervitization with menthylchloroformate as CDA using
GC-MS. Table 5 shows developed methods for quantitative analysis of synthetic
cathinones in biological materials using GC-MS.
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Table 5: Synthetic cathinones analysis in biological materials using GC-MS
Targets

Samples

Purification Derivatization

LOD

36 Synthetic
cathinones

Urine
and
plasma

SPE

L-TPC

6 Synthetic
cathinones

Urine

SPE

2,2,25 – 20
Trichloroethyl ppb
chloroformate

1–
1000
ppb

(Hong et
al., 2015)

18 Synthetic
cathinones

Urine

Liquid –
liquid
extraction
(LLE)

Trifluoroaceti
c anhydride
(TFAA)

100 –
1000
ppb

(Gerace et
al., 2019)

6 Synthetic
cathinones
and other
NPSs

Urine
and
blood

SPE

Pentafluoropr
opionic
anhydride
(PFPA)

0.21.0
ppb

0.5 –
50 ppb
50 –
2000
ppb

(Nisbet et
al., 2019)

22 Synthetic
cathinones

Urine

SPE

Pentafluoropr
opionic
anhydride
(PFPA)

0.5 –
10 ppb

50 –
2000
ppb

(Alsenedi
and
Morrison,
2018)

0.26 –
0.34
ppb

10 –
30 ppb

Linear
range
1–
100
ppb

Reference
(Alremeit
hi et al.,
2018)

1.5.4.1 Mass Spectrometry (MS)
In this work, mass spectrometry (MS) was coupled with gas chromatography
(GC) for the quantitative determination of synthetic cathinones. MS has grown rapidly
in the past few decades with its applications in different scientific disciplines in both
health and life science. MS works by the formation of ions (negatively or positively
charged) in gas phase which can be separated magnetically or electrically based on
their mass-to-charge ratio (m/z). The MS output or spectrum plots m/z vs. intensity
which represents the analyzed compound ions and its corresponding fragmented ions.
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MS can provide information regarding the composition, structure and the purity of the
analyzed compound (El-Aneed et al., 2009).
In addition, many scientists use the sequential mass spectrometry or sometimes
called tandem mass spectrometry (MS/MS) instead of the single mass spectrometry
(ms) instrument as an analytical detector. This technique applies the use of multiple
quadrupole instruments which can do different tasks such mass selection of the
targeted compound (precursor ion), further fragmentation of the targeted compound
(product ions), and m/z analysis of the resulted ions (Dass, 2010). The process of
fragmentation and ions activation occurs in the reaction region of the instrument via
collision induced dissociation (CID). CID depends on natural gases such as helium,
argon, or nitrogen to convert the translational energy of the targeted precursor ion into
internal energy resulting in the formation of product ions of that precursor. The
fragmentation intensity or pattern depends on the collision energy (high or low-energy)
used in CID (Niessen, 2017). Using tandem MS substantially increases the sensitivity
and selectivety of the analytical method especially with complex matrices (Portolés et
al., 2012).
In general, mass spectrometry (MS) consists of an ion source which produces
gas phase ions, single or multiple mass analyzers to separate the ions based on their
mass-to-charge ratio (m/z), and a detector. Ionization (ion formation) is considered the
first step in MS analysis.There are common ion sources or ionization methods used in
MS such as electron ionization (EI) source, chemical ionization (CI) source, and
electrospray ionization (ESI) source. Electron impact ionization (EI) works by
producing accelerated electrons capable of impacting the sample vapor (targeted
molecules) resulting in the removal of one other electron from the molecule to form a
radical cation [M+.]. The produced molecule cations can be further fragmented by
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another impacting electron from the EI source. On the other hand, chemical ionization
(CI) is considered a soft ionization technique compared to EI. It works by ionizing the
ionization gas (such methane or ammonia) using accelerated electrons generated by a
filament, followed by chemical interaction of the ionized gas with the sample
molecules. Usually, a proton transfer is involved in CI. Moreover, ESI is another
common source of ionization where a high voltage is used to convert the pumped
analytical solution into ionized spray or small charged droplets. ESI is mainly used
and easily interface the liquid chromatogram (LC) and the capillary electrophoresis
(CE) with mass spectrometry (de Hoffmann, 2005).
1.5.4.2 Negative Chemical Ionization (NCI)
Chemical inonization (CI) is an ionization method used as a standard or
optional feature in most commercially available mass spectrometry (MS) that can be
performed using a wide range of reagent gases. The reagent gases such as methane,
ammonia, and isobutane are used to generate positive or negative ion mass capable of
chemically interacting and ionizing molecules of the targeted sample. Moreover, the
resulted ions from the first interaction (collision) of the ion reagent with the molecules
can undergo further ion/molecules reactions to produce higher order products. CI
normally results in a less energetic (softer) ionization of the targted sample than
electron ionization (EI). In addition, CI provides a higher sensitivity for quantitative
analysis than EI (Westmore and Alauddin, 1986).
One form of chemical ionization (CI) is the production of negative plasma ions
by the CI source which have the ability to react with substrate molecules. This form of
CI is called negative chemical ionization (NCI) that can be produced using series of
reagent gases with the ability to produce quasi-molecular or molecular ions to analyze
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compounds of medical, environmental, or biological interest. The gaseous molecules
will be inonized inside the inoization source and interact with the anlayts to produce
negative ions. NCI is a selective and sensitive technique for analytes capable of
forming stable negative ions. Some of these well known reagents used in NCI are
methane, ammonia, and isobutane (Budzikiewicz, 1986).
Among the different ionization sources, electron ionization (EI) has
been the most used source of ionization in mass spectrometry (MS). EI is considered
a hard ionization source and usually results in high and extensive fragmentation of the
compound of interest which compromises the sensitivity of the analytical method. To
overcome the EI disadvantages, softer ionization technique such as chemical
ionization (CI) can be used to achieve better sensitivity, lower signal-to-noise (S/N)
ratio, and overall enhancement in chromatographic and mass spectral signals (Portolés
et al., 2012). For example, Húšková el al. had reported and compared the separation of
pesticides in different matrices using GC-NCI-MS (gas chromatography-negative
chemical ionization-mass spectrometry), GC-PCI-MS (gas chromatography-positive
chemical ionization-mass spectrometry), and GC-EI-MS (gas chromatographyelectron impact ionization-mass spectrometry) systems. Methane was used as a reagent
gas for the NCI. GC-NCI-MS system provided a better signal-to-noise ratio (S/N), and
lower limit of detections (LODs) compared to both GC-PCI-MS and GC-EI-MS
(Húšková et al., 2009). Another example is the use of GC-NCI-MS system by
Alremeithi et al. for quantitative determination of synthetic cathinone enantiomers in
urine and plasma. The article compares the obtained results of the study with a
previously reported analytical method for quantitative determination of the same drugs
using GC-EI-MS. Comparing the results using GC-NCI-MS method with GC-EI-MS,
GC-NCI-MS showed an enhancement in the sensitivity by two orders of magnitude
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(Alremeithi et al., 2018). Table 6 shows publications used negative chemical ionization
(NCI).
Table 6: Recent publications using negative chemical ionization (NCI)
Targets

Samples

Instrument

Reference

Sugar phosphates

Cancer cell

GC-NCI-MS

(Okahashi et al.,
2019)

Pesticide

Fruits and
vegetables
Human blood

GC-NCI-MS

(Besil et al., 2015)

GC-NCI-MS

(Kuiper et al.,
2018)

10 Perfluorinated
carboxylic acids

Water

GC-NCI-MS

(Wang et al.,
2019)

Synthetic cannabinoids

Standards

GC-NCI-MS

(Umebachi et al.,
2017)

Non-steroidal antiinflammatory drugs
(NSAIDs)

Water

GC-NCI-MS

(Marsik et al.,
2017)

Five kinds of banned
drugs (two hormones,
two sedatives, and one
chloramphenicol)

Milk powder

GC-NCI-MS

(Wu et al., 2015)

Psychoactive substance Postmortem
(MDPBP (1-(3,4human blood
methylenedioxyphenyl)- samples
2-(1-pyrrolidinyl)-1butanone))

GC-NCI-MS

(Wiergowski et al.,
2016)

6 Cannabinoids and
metabolites

GC-NCI-MS

(Desrosiers et al.,
2015)

GC-NCI-MS

(Kannenberg et al.,
2018)

Trans-fatty acids

Oral fluids

Testosterone (T) and 5α- Spiked serum
dihydrotestosterone
samples
(DHT)
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1.5.4.3 Other Analytical Methods
From the past few decades, new analytical techniques have been evolved to
support the high demands for drugs discovery, development and anlaysis. As a result,
these developed techniques provide accurate and precise detection and quantitation
analysis for newly designed drug substances. Moreover, the developed analytical
techniques play a very important role in the basis of designing highly efficient drugs,
studying the degradation process of these drugs, and evaluating their quality
(Ramachandra, 2017).
Like many other synthetic drugs, synthetic cathinones have been causing
serious social problems worldwide. In order to cope with the rapid changes in chemical
structures of these new designer drugs (NDD), forensic scientists are continually
modifying their exciting screening methods using different analytical approaches to
detect and quantify those types of drugs in seized and biological materials. In addition
to gas chromatography (GC), high performance liquid chromatography (HPLC) and
capillary electrophoresis (CE) have been also used for analyzing synthetic cathinones
in seized and biological materials (Fabregat-Safont et al., 2019) (Baciu et al., 2016).
High performance liquid chromatography (HPLC) is among the most
frequently used methods for chiral compounds separation. A high-resolution
separation is usually obtained when using chiral stationary phases (CSPs) such as
ligand-exchange-type CSPs, cyclodextrin-based CSPs, polyamide-based CSPs,
polysaccharide-based CSPs, and protein-based CSPs (Okamoto and Ikai, 2008).
An inexpensive method for chiral separation of 25 synthetic cathinones was
developed using high performance liquid chromatography coupled with Ultraviolet
detector (HPLC-UV). The developed method used achiral column with a mobile phase
consists of methanol, water, and sulfated-β-cyclodextrin (S- β CD) (Taschwer et al.,
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2014). Ambach et al. were able to separate and quantify 56 new psychoactive
substances (NPSs) including synthetic cathinones in whole blood and urine using
HPLC-MS/MS with a chiral column (Ambach et al., 2015). Table 7 shows recent
published methods for quntitative analysis of synthetic cathinones in biological
materials using high performance liquid chromatography (HPLC).
Table 7: Synthetic cathinones analysis in biological materials using HPLC
Targets

Samples
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Urine
Synthetic and
cathinones plasma

Purification

Detector

LOD

SPE

HPLCUV-VIS

1 – 1.47
PPM

NPSs
Urine
including
cathinones

SPE

HPLCMSMS

0.14 –
0.67 PPM
0.01 – 2.3
ppb
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Urine
Synthetic and
cathinones blood

SPE

HPLCMSMS

0.25 – 5
ppb

Linear
range
5 – 250
ppm

Reference
(Meetani
et al.,
2019)

1–
2000
ppb

(Borovcov
á et al.,
2018)

5–
1000
ppb

(Glicksber
g et al.,
2016)

1 – 5 ppb
4′-methylαpyrrolidin
ohexanop
henone
(MPHP)

Urine

16 NPSs
Blood
including
cathinones

SPE

HPLCMSMS

0.5 ppb

1 – 100
ppb

(ShintaniIshida et
al., 2016)

Micro-SPE
And LLE

LCMSMS

0.2 ppb

5 – 500
ppb

(Montesan
o et al.,
2017)

Capillary electrophoresis (CE) has also been a technique of choice for
quantitative analysis of synthetic cathinones and other drugs (Merola et al., 2014). CE
is considered a new technique compared to GC and LC, and it is usually used in
analytical studies as a complementary tool for LC and GC. CE uses a small capillary
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to separate charged analytes under the impact of an electric field. It has the advantages
of short analysis time, smaller sample size (nano scale), and low running cost
compared to GC and LC (Siddiqui et al., 2017). In addition, CE have been recently
used for chiral separation of synthetic cathinones and other chiral compound using
modified cyclodextrins as chiral selectors (Řezanková et al., 2018). For synthetic
cathinones quantitative analysis, CE is usually coupled with mass spectrometry (MS)
detector (Cui et al., 2018) or ultraviolet (UV) detector (Merola et al., 2014). Merola et
al. have developed a rapid chiral separation of 12 synthetic cathinones using
cyclodextrin-assisted capillary electrophoresis (CE) coupled with ultraviolet (UV) and
mass spectrometry (MS) detectors. The conducted research provided high resolution
separation of the targeted synthetic cathinones with detection limits down to 1.0 ppb
were obtained (Merola et al., 2014). Recently, Nowak et al. have investigated eight
cyclodextrins as potential chiral selectors for chiral separation of three commonly
abused synthetic cathinones (ephedrone, mephedrone and metaphedrone) using CE
equipped with a diode array detector (DAD). Among the different tested cyclodextrins,
2-hydroxyethyl-β-cyclodextrin was reported to be the most efficient enantioselector
for the targeted compounds (Nowak et al., 2018). As seen in Table 3, cyclodextrin
derivatives are the most common chiral selectors used with capillary electrophoresis
(CE).
The work presented in this thesis describes research into the development of
an analytical method for the analysis of ten (10) synthetic cathinones using gas
chromatography tandem mass spectrometry (GC-MSMS) with negative chemical
ionization (NCI) and multiple reaction monitoring (MRM) mode. The studied
synthetic cathinones were converted into their two corresponding enantiomers after a
reaction with menthylchloroformate (MCF) chiral derivatizing agent (CDA). A
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racemic mixture of the ten synthetic cathinones was qualitativly and quantitativly
analyzed in spiked urine samples as well as method validation. Scheme 6 shows the
structure of the ten studied synthetic cathinones and the internal standard (IS) used in
this thesis.
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Scheme 6: Chemical Structures of the Ten Synthetic Cathinones and the Internal
Standard (IS)
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Chapter 2: Methods
2.1 Chromatographic Condition
Chromatographic separation was performed on an Agilent 7890A GC equipped
with a 7693B autosampler and 7000 Series triple quadrupole (QQQ) mass
spectrometer detector, MSD system (Agilent, USA). An Agilent Ultra Inert 60 m
capillary column consisting of (5%-Phenyl)-methylpolysiloxane, with 0.25 mm inner
diameter and a 0.25 µm film thickness was used as stationary phase. Chemical
ionization (CI) with methane gas (40%, 2.0 mL/min) was employed in the negative
ion mode at a voltage of 110 eV. Helium was used as carrier gas at a constant flow rate
of 1.0 mL/min. An injection of 3 µL of sample solution was performed automatically
in splitless mode. The injector and GC–MS interface line temperature were set at 250
and 280 oC, respectively. Data collection was performed in Multiple Reaction
Monitoring (MRM) mode as shown in Table 8 starting at 42 min after injection (i.e.,
filament delay). The column temperature program was as follows: starting at 160 oC
and hold for 5 min, followed by heating to 270 oC with a heating rate of 2 oC/min. The
final temperature was held at 270 oC for 5 min.
The obtained data was analyzed using the Agilent Mass Hunter Workstation
software B.06.00.
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Table 8: Time segments table with selected fragments (ions) in MRM mode for the
analysis of cathinones mixture
Compound Name

2-Fluoromethcathinone

Abbreviation

2-FMC

Time

44.00-

Precursor

Fragment

(m/z)

(m/z)

363.5

212, 155

377.5

226, 155

359.8

344, 212,

359.5

155, 145

373.8

344, 188,

45.55
2-Fluoroethcathinone

2-FEC

45.5547.20

Buphedrone
3-Methymethcathinone

3-MMC (IS)

49.00

(Internal Standard)
4-Methylethcathinone

47.20-

4-MEC

155
3-Methylbuphedrone

3-MethylBP

49.00-

373.8

212, 174

373.5

217, 173

387.8

226, 155

387.5

231, 188

424.7

211, 81

403.5

212, 190,

51.65
2,4-Dimethylmethcathinone

2,4-DMMC

4-Methyl- α51.65-

ethylaminobutiophenone
3,4-Dimethylethcathinone
4-Bromoethcathinone

3,4-DMEC
4-BMC

53.70
55.1058.00

Butylone

-

58.0065.00

Development of an acquisition method for the 7890A Series
The procedure involves the following tasks:
Task 1: Setting the inlet and injection parameters
Task 2: Entering GC acquisition parameters
Task 3: Creating an acquisition method to find precursor ions (Scan mode)
Task 4: Acquiring precursor ion scan data

175, 155
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Task 5: Determining precursor ion masses
Task 6: Creating an acquisition method to find product ions (Product scan mode)
Task 7: Acquiring product ion scan data
Task 8: Determining product ion masses
Task 9: Creating the MRM method
Task 10: Acquiring MRM data
Task 11: Creating an MRM quantitative analysis method
2.2 Chemicals and Reagents
All chemicals were of analytical grade. Triethylamine, acetonitrile, methanol,
2-propanol,

hexane,

dichloromethane,

ammonium

hydroxide,

(1R)-(-)-

Menthylchloroformate 99% purity, and sodium phosphate were obtained from SigmaAldrich Chemicals (St. Louis, MO, USA). Doubly deionized water was obtained from
ultra-pure Millipore system (MS, USA). All synthetic cathinones standards shown in
Table 2 were purchased from Cayman chemicals (Michigan, USA) by Dubai Police,
Dubai and were kindly gifted to us. Synthetic cathinones standards used in this study
were supplied as racemic mixtures of R and S enantiomers.
2.3 Sample Preparation
2.3.1 Samples
This work conforms to the UAE community guidelines for the use of humans'
samples in experiments.
2.3.2 Stock Solution
All synthetic cathinones samples were obtained in powdered form. For GC
analysis, each sample was dissolved in 50 µL triethylamine and certain amount of
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acetonitrile to obtain final concentration of 1000 ppm for each. Stock solutions were
further diluted with acetonitrile to obtain the desired concentrations.
2.3.3 Urine Spiking and Solid Phase Extraction (SPE)
Solid phase extraction (SPE) was carried manually and offline. Column was
200MG clean screen CSDAU203 from FluoroChem, (Hadfield, UK). Urine sample
was diluted with doubly deionized water in 1:1 ratio. 2 mL of diluted urine was spiked
with 1 mL of 50 ppm synthetic cathinones mixture and internal standard (IS) 3Methylmethcathinone (3-MMC) in addition to 1 mL of 0.1 M phosphate buffer (pH
6.0). The mixture was mixed and vortexed for 1 min. For SPE cartridge conditioning,
1 mL of methanol and 1 mL of doubly deionized water were used. 2 mL of spiked
urine sample was loaded to the cartridge followed by sequential washing using 1 mL
0.1 M acetic acid and 1 mL methanol. The cartridge was left for drying under soft air
stream for 1 min. Finally, 3 mL of the eluate mixture, which is made of
dichloromethane, hexane, isopropanol, and ammonium hydroxide with a relative ratio
of (39:39:20:2) was used to collect the analyte. The collected sample was evaporated
to dryness under soft air stream.
2.3.4 Derivatization Step
Derivatization reaction was done for the spiked urine samples after the
evaporation step in SPE. The obtained dried and free of water sample was dissolved
in 50 µL of triethylamine and 850 µL acetonitrile to obtain final concentration of 50
ppm. 500 µL of the 50-ppm sample was reacted with 35 µL of menthylchloroformate
CDA and vortex for 10 min at room temperature. The derivatized sample was stored
in the freezer for 24 hrs. prior to injection in GC-MS instrument.

34
2.4 Method Validation
The adopted analytical approach and performance in this study was validated
in terms of linearity, sensitivity (Limit of Detection (LOD), Limit of Quantitation
(LOQ)), intraday and interday reproducibility, and recovery for all tested spiked urine
samples.
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Chapter 3: Results
3.1 GC-MS/MS Database Development
The GC-MS/MS method was developed by creating a quantitative analysis
method, which consist of the following steps: (1) precursor ions scanning and
determination, (2) creation of acquisition data file for the determined precursor ions,
(3) precursor ions fragmentation at different collision energies, (4) product ion
determination for each compound, (5) determination of the most suitable collision
energies, (6) MRM method creation. Table 9 shows the compound name, the
determined precursor ion of each compound, the resulted product ions for each
compound, the suitable collision energy and the retention time of each.
Table 9: MRM acquisition parameter for the analysis of cathinones mixture in urine
No

Compound

Time
(min)

Precursor
Ion (m/z)

Product
Ion (m/z)

Collision
energy (v)

Dwell
Time (ms)

1

2-FMC

363.5

212, 155

10,15,20,25

100

2

2-FEC

44.0045.55
45.5547.20

377.5

226, 155

10,15,20,25

100

3

Buphedrone

359.8

344, 212,
155, 145
202, 188

10,15,20,25

100

10,15,20,25

100

373.8

344, 188,
155

10,15,20,25

100

373.8

212, 174

10,15,20,25

100

373.5

217, 173

10,15,20,25

100

387.8

226, 155

10,15,20,25

100

387.5

231, 188

10,15,20,25

100

424.7

211, 81

10,15,20,25

100

403.5

212, 190,
175, 155

10,15,20,25

100

IS

3-MMC

4

4-MEC

5

3-MethylBP

6

2,4-DMMC

7

8

4-Methyl- αethylaminobutioph
enone
3,4-DMEC

9

4-BMC

10

Butylone

47.2049.00

49.0051.65

359.5

51.6553.70

55.1058.00
58.0065.00
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3.2 Cathinones Enantiomers Separation
One of the specific objectives of this research work is separate and convert
each synthetic cathinone into two enantiomers using the pure chiral derivatizing agent,
Menthylchloroformate (Scheme 7).

Scheme 7: Derivatization Reaction between Cathinone and Menthylchloroformate
The ten synthetic cathinones reacted with the derivatizing agent MCF. The
reaction took place between the acid chloride in the derivatizing agent and the amine
group of the targeted compound. Figure 1 shows the separation of the (R) and (S)
enantiomers of Butylone drug after derivatization with MCF.
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Figure 1: GC Chromatogram for separation of the R and S enantiomers of Butylone
drug in acetonitrile after derivatization with MCF
All ten tested compounds were derivatized using MCF under the same
conditions. Each compound was analyzed individually on GC-NCI-MS using MRM
mode. Table 10 shows the retention time, resolution values and selectivity factor of
the separated enantiomers for the ten analyzed synthetic cathinones.
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Table 10: List of the analyzed synthetic cathinones, internal standard and their
synonyms, in addition to the retention times of the separated two enantiomers for
each compound analyzed on GC-MS using MRM mode
#

Compound Name

Abbreviation

Time (min)
tR1

tR2

Resolution Selectivity
Factor (α)

1

2-Fluoromethcathinone

2-FMC

44.75 45.13

2.95

1.008

2

2-Fluoroethcathinone

2-FEC

46.25 46.50

2.74

1.005

3

Buphedrone

-

47.40 47.75

2.89

1.007

IS

3-Methylmethcathinone

3-MMC

58.75

4

4-Methylethcathinone

4-MEC

50.50 50.75

2.44

1.005

5

3-Methylbuphedrone

3-MethylBP

50.50 50.83

2.85

1.006

6

2,4Dimethylmethcathinone

2,4-DMMC

52.10 52.80

3.33

1.013

7

4-Methyl- αethylaminobutiophenone

-

52.30 52.70

1.83

1.008

8

3,4-Dimethylethcathinone

3,4-DMEC

53.00 53.30

1.66

1.006

9

4-Bromoethcathinone

4-BMC

55.30 55.55

1.24

1.004

-

61.40 61.75

2.60

1.007

10 Butylone

39
Figure 2 shows the GC total ion chromatogram (TIC) for the analyzed synthetic
cathinones mixture after being spiked in urine followed by SPE and derivatization step
using MCF. A good separation can be observed of the mixture components.

c

Abundan
ce

e&
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a

b

g h
i

j
k

d

Time
Figure 2: Total Ion Chromatogram (TIC) of the simultaneous(min)
chiral separation of ten synthetic cathinone compounds. The mixture was spiked in
urine and separated by MCF
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GC chromatograms of compounds with similar retention time such as 4-MEC
and 3-MethylBP, as shown in Figures 3 and 4 respectively, are obtained by extracting
the specific chromatogram of each compound. In addition, 2,4-DMMC has one of its
enantiomers overlapping with 4-Methyl- α-ethylaminobutiophenone in terms of
retention time. 2,4-DMMC is extracted from the TIC as shown in Figure 5.

Abundance

Abundance

4-MEC

Time (min)
Figure 3: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-MEC
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Abundance

Abundance

3-MethylBP

Time (min)
Figure 4: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 3-MethylBP
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Abundance

Abundance

2,4-DMMC

Time (min)
Figure 5: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2,4-DMMC
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Moreover, the rest of the separated synthetic cathinones were also extracted
from the obtained total ion chromatogram (TIC) of the simultaneous chiral separation
of the synthetic cathinones mixture spiked in urine for more accurate determination
and quantitative analysis. Figures 6-12 shows the extracted ion chromatogram (EIC)
for 2-FMC, 2-FEC, Buphedrone, 4-Methyl- α-ethylaminobutiophenone, 3,4-DMEC,
4-BMC, and Butylone respectively.

Abundance

Abundance

2-FMC

Time (min)
Figure 6: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2-FMC
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Abundance

Abundance

2-FEC

Time (min)
Figure 7: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2-FEC
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Abundance

Abundance

Buphedrone

Time (min)
Figure 8: Extracted Ion Chromatogram (EIC) of R and S enantiomers of Buphedrone
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Abundance

Abundance

4-Methyl- α-ethylaminobutiophenone

Time (min)
Figure 9: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-Methyl- α-ethylaminobutiophenone
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Abundance

Abundance

3,4-DMEC

Time (min)
Figure 10: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 3,4-DMEC
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Abundance

Abundance

4-BMC

Time (min)
Figure 11: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-BMC
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Abundance

Abundance

Butylon
e

Time
(min)
Figure 12: Extracted Ion Chromatogram (EIC) of R and S enantiomers of Butylone
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3.3 Method Validation
Method validation was performed on the ten analyzed compounds spiked in
urine matrix. Method was validated in terms of calibration curve linearity, sensitivity
(Limit of Detection (LOD), Limit of Quantitation (LOQ)), intraday and interday
reproducibility, and spike recovery.
The calibration graphs for the ten enantiomer pairs of the synthetic cathinones
were obtained in a linear form within the tested range of 0.5 to 50 ppm in urine with
mean regression coefficient (R2; n=5) of 0.98 or higher. Figure 13 shows the
calibration graphs of the two 2-FMC enantiomers in urine mixture.
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Figure 13: Calibration graphs of the two separated enantiomers of 2-FMC compound
spiked in urine obtained within 0.5-50 ppm range. a) E1 URINE b) E2 URINE
The sensitivity of the method was validated in terms of limit of detection
(LOD) and limit of the quantitation (LOQ) for the two separated enantiomers of each
of the ten analyzed synthetic cathinone compounds in urine. Table 11 summarizes the
regression coefficient, LOD and LOQ of the separated enantiomers of every analyzed
compound in urine.
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Table 11: Regression coefficient R2 values, limits of quantitation (LOQ) and limits of
detection (LOD) for the ten synthetic cathinone compounds spiked in urine

R2 ± SD
Name
1

2-FMC

2

2-FEC

3

Buphedrone

4

4-MEC

5

3-MethylBP

6

2,4-DMMC

7

4-Methyl- αethylaminobutiophe
none

8

3,4-DMEC

9

4-BMC

10

Butylone

LOQ ± SD (ppm)

LOD ± SD (ppm)

E1

E2

E1

E2

E1

E2

0.9893 ±
0.0150
0.9896±
0.0227
0.9924 ±
0.1133
0.9939 ±
0.1055
0.9938 ±
0.0049
0.9906 ±
0.0010

0.9879 ±
0.0150
0.9827 ±
0.0285
0.9921 ±
0.1560
0.9929 ±
0.1027
0.9917 ±
0.0060
0.9939 ±
0.0023

0.142 ±
0.0021
0.062 ±
0.0004
0.013 ±
0.0005
0.030 ±
0.0032
0.347 ±
0.0002
2.493 ±
0.0007

0.135 ±
0.003
0.063 ±
0.0003
0.012 ±
0.0004
0.028 ±
0.0003
0.621 ±
0.0681
1.878 ±
0.0005

0.047 ±
0.0007
0.020 ±
0.0003
0.004 ±
0.0002
0.010 ±
0.0010
0.114 ±
0.0009
0.823 ±
0.0002

0.045 ±
0.0003
0.021 ±
0.0001
0.004 ±
0.0004
0.009 ±
0.0001
0.205 ±
0.0224
0.620 ±
0.0002

0.9973 ±
0.0077
0.9937 ±
0.0002
0.9912 ±
0.0618

0.9904 ±
0.0129
0.9912 ±
0.0008
0.9904 ±
0.0389

0.421 ±
0.0171
9.536 ±
0.3699
0.059 ±
0.0014

0.222 ±
0.0030
3.429 ±
0.0160
0.089 ±
0.0009

0.139 ±
0.0006
3.147±
0.1221
0.019 ±
0.0005

0.073 ±
0.0011
1.131 ±
0.0528
0.029±
0.0003

0.9886 ±
0.0354

0.9935 ±
0.0413

0.094 ±
0.0010

0.091 ±
0.0013

0.031 ±
0.0002

0.030 ±
0.0004

For the accuracy and reproducibility validation of this study, intraday and
interday reproducibility were obtained by testing two different concentration levels
(10 ppm and 25 ppm) for the two separated enantiomers of each of the ten analyzed
synthetic cathinone compounds in urine as shown in Table 12. For intraday, each of
the two concentration levels was run twice in the same day and the same concentration
levels were run twice on the second day for interday reproducibility. The
reproducibility results were obtained in terms of coefficient of variance for the ten
analyzed synthetic cathinone compounds in urine.
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Table 12: Intraday and interday reproducibility results for the ten synthetic cathinone
compounds spiked in urine at two different concentration levels for the two
enantiomers of each compound
CV% Intraday
10 ppm

CV% Interday

25 ppm

10 ppm

25 ppm

E1

E2

E1

E2

E1

E2

E1

E2

1

2-FMC

1.40

2.40

2.56

2.09

2.33

3.18

4.77

2.40

2

2-FEC

3.77

0.89

1.01

2.97

7.75

3.22

3.71

6.14

3

Buphedrone

3.15

2.74

1.73

1.23

3.68

4.77

6.33

2.92

4

4-MEC

6.71

2.61

1.36

4.56

9.77

7.41

2.57

7.29

5

3-MethylBP

4.03

1.15

2.22

3.70

12.24

6.62

4.52

10.16

6

2,4-DMMC

2.57

2.33

4.82

5.93

3.63

2.69

9.85

10.33

7

4-Methyl- αethylaminobutiophe
none

6.27

4.36

1.21

2.49

9.35

6.21

4.81

7.83

8

3,4-DMEC

3.60

7.77

6.30

2.13

4.57

9.68

7.04

4.66

9

4-BMC

1.71

1.95

1.38

2.40

3.45

3.98

1.64

4.88

10

Butylone

2.56

1.29

1.45

1.19

2.85

1.29

2.82

1.94

For the recovery study, an evaluation of the percent error has been done for the
spiked mixture in urine at two different concentration levels (10 ppm and 25 ppm) as
shown in Table 13.
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Table 13: Recovery measurements expressed in percent errors for the ten synthetic
cathinone compounds spiked in urine at two different concentration levels for the
two enantiomers of each compound
Error %
10 ppm

25 ppm

E1

E2

E1

E2

1

2-FMC

2.36

6.23

8.77

11.57

2

2-FEC

3.07

4.46

5.19

4.12

3

Buphedrone

5.14

6.23

8.77

11.70

4

4-MEC

7.52

3.69

3.64

4.91

5

3-MethylBP

3.34

5.72

4.04

4.88

6

2,4-DMMC

4.98

3.74

7.41

9.09

7

4-Methyl- αethylaminobutiophenone

9.57

2.64

7.92

10.64

8

3,4-DMEC

5.19

6.76

8.46

4.17

9

4-BMC

2.39

3.14

2.29

4.98

10

Butylone

3.95

2.86

3.91

2.98
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Chapter 4: Discussion
This

study

adopts

the

indirect

chiral

separation

method

using

Menthylchloroformate (MCF) as a chiral derivatizing agent (CDA). MCF reacted with
secondary amine enantiomers of the ten analyzed synthetic cathinone derivatives
resulting in two corresponding diastereoisomers of each of the ten compounds. The
resulted diastereoisomers from the reaction of synthetic cathinones with MCF
interacted differently with the achiral stationary phase column and were presented in
different retention time on the gas chromatography (GC) chromatogram. All ten
analyzed synthetic cathinone compounds (Table 8) have been derivatized by MCF and
the interaction resulted in the formation of a two-unique corresponding enantiomers of
each of the ten analyzed compounds. The total ion chromatogram (TIC) of the
synthetic cathinones mixture spiked in urine showed different corresponding pairs of
enantiomers with different resolutions and intensity of the products. This difference is
suggested to be caused by the difference of physicochemical properties such as
stereochemistry and stability of the analyzed compound on the achiral column.
Moreover, the structure difference, the distance between the two asymmetric centers
in the substrate and CDA, and the conformational rigidity around the chiral center
might influence the difference in resolution and intensity of the resulted corresponding
enantiomers (Toyo’oka, 2002). Using the Multiple Reaction Monitoring (MRM) mode
for the collection of data, it was possible to separate the ten analyzed synthetic
cathinone compounds simultaneously in one chromatogram after spiking them in urine
(Figure 2). The obtained TIC (Figure 2) had two synthetic cathinone compounds
sharing the similar retention time 4-MEC and 3-MethylBP. By extracting the specific
chromatogram of each of the two compounds, it was possible to determine and
quantify them separately (Figures 3 and 4). In addition, one compound (2,4-DMMC)
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had one of its enantiomers overlapping with 4-Methyl- α-ethylaminobutiophenone in
terms of retention time. It was possible to determine and quantify the compound by
extracting its exact ion chromatogram (EIC). In addition, the rest of the separated
synthetic cathinones were also extracted from the obtained TIC for more accurate
determination and quantitative analysis. Calibration curves of the ten analyzed
synthetic cathinone compounds in urine were constructed based on the two
corresponded enantiomers peak areas of each compound in the tested range (0.5 to 50
ppm). 3-Methylmethcathinone (3-MMC) was added as an internal standard (IS) to the
ten analyzed synthetic cathinones mixture. 3-MMC was chosen due to its similar
structure to the studied synthetic cathinone compound and its good reactivity with
MCF. 3-MMC was previously investigated and its reaction with MCF resulted in the
formation of one peak. This formation of one peak can be explained as that the 3-MMC
compound we have is a pure (R) or (S) enantiomer or one of the enantiomers has a
higher reactivity with MCF compared to the other. Figure 13 shows the calibration
graphs of the two separated enantiomers of 2-FMC compound spiked in urine. All
constructed graphs showed linearity and good correlation coefficient (R2) values
higher than 0.98 as shown in Table 11. Table 11 also shows the Limits of Quantitation
(LOQ) and Limits of Detection (LOD) values for each enantiomer for the ten analyzed
synthetic cathinone compounds mixture spiked in urine. For LOQ in urine, the range
was 0.012 – 9.536 ppm and for LOD the range was 0.004 – 3.147 ppm. Both LOQ and
LOD were measured based on signal-to-noise (S/N) method (Shrivastava and Gupta,
2011).
Intraday and interday reproducibility of the ten analyzed synthetic cathinones
mixture were evaluated and reported at two different concentration levels (10 and 25
ppm) as shown in Table 12. For intraday, each of the two concentration levels was run
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twice in the same day and the same concentration levels were run twice on the second
day for interday reproducibility. The method reproducibility was evaluated based on
the coefficient of variance values and all the analyzed enantiomers showed values
below 12.3% in urine suggesting a good reproducibility of the adopted method.
For the evaluation of the adopted solid phase extraction (SPE), the method
recovery has been studied by calculating the percent error for the ten analyzed
synthetic cathinones mixture in urine at two different concentrations (10 and 25 ppm).
The percent error values were within the acceptable range for most of the enantiomers
in urine.
4.1 Data Comparison
Alremeithi et al. have recently published a research article titled “Simultaneous
Quantitative Determination of Synthetic Cathinone Enantiomers in Urine and Plasma
Using GCI-NCI-MS”. They were able to indirectly separate 36 synthetic cathinone
compounds using (S)-(-)-N-(Trifluoroacetyl) pyrrolidine-2-carbonyl chloride (L-TPC)
as chiral derivatizing agent (CDA). In addition, 14 synthetic cathinones were
quantitatively determined after being spiked in urine and plasma followed by
derivatization step using L-TPC (Alremeithi et al., 2018). Among the 14 synthetic
cathinones in Alremeithi et al. article, four synthetic cathinones including Buphedrone,
3-MethylBP, 3,4-DMEC, and Butylone were studied in this research work. Those four
compounds were compared in both studies in terms of LOQs and LODs as shown in
Table 14.
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Table 14: LOQs and LODs Data Comparison
Presented Thesis

(Alremeithi et al., 2018)

LOQ (ppm)

LOD (ppm)

LOQ (ppm)

LOD (ppm)

Name

E1

E2

E1

E2

E1

E2

E1

E2

1

Buphedrone

0.013

0.012

0.013

0.012

9.6x10-4

9.2x10-4

2.9x10-4

2.8x10-4

2

3-MethylBP

0.347

0.621

0.347

0.621

1.02x10-3

9.9x10-4

3.1x10-4

3.0x10-4

3

3,4-DMEC

9.536

3.429

9.536

3.429

1.12x10-3

1.39x10-3

3.410-4

4.2x10-4

4

Butylone

0.094

0.091

0.094

0.091

8.6x10-4

9.8x10-4

2.610-4

2.7x10-4

As shown in Table 14 above, Alremeithi et al. results show better sensitivity in
terms of LOQs and LODs for the four synthetic cathinones. In addition, the adopted
method using L-TPC as CDA showed better separation (baseline separation) for most
of the analyzed compounds compared to our results. Both studies (this work and
Alremeithi et al.) have used GC-NCI-MS and the main difference was the type of chiral
derivatizing agent used.
We were expecting to obtain better results in terms of resolutions, LOQs, and
LODs by using menthylchloroformate (MCF) as chiral derivatizing agent (CDA). Due
to the use of only one bottle of MCF from one source (manufacture), it is possible that
the purity of MCF had affected the overall reaction with the targeted synthetic
cathinone compounds. Moreover, the derivatization reaction took place under
controlled anhydrous condition due to high reactivity of MCF with water and to
maximize the reaction efficiency. Despite the adequate care given to minimize any
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possible experimental errors, there are still errors (random or systematic) such as
instrumental setup, samples purity, derivatizing agent reactivity, extraction efficiency
and recovery might affect the overall experimental design.
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Chapter 5: Conclusion
A sensitive and selective analytical method for separation and quantitative
determination of synthetic cathinones in urine using gas chromatography tandem mass
spectrometry (GC-MSMS) was successfully developed. The developed method adopts
the indirect chiral separation technique using menthylchloroformate (MCF) as chiral
derivatizing agent. A mixture of ten synthetic cathinones was spiked in urine followed
by

solid

phase

extraction

(SPE)

and

derivatization

using

MCF.

3-

Methylmethcathinone (3-MMC) was used as an internal standard (IS) in synthetic
cathinones quantitation due to similar structure to the analyzed compounds. The ten
derivatized synthetic cathinones mixture in urine were separated as their optical
enantiomers successfully using a 60 m achiral stationary phase column in GC.
Calibration curves of the ten analyzed synthetic cathinones in urine were constructed
based on the two corresponded enantiomers peak areas of each compound in the tested
range (0.5 to 50 ppm). The analytical method was validated in terms of calibration
curve linearity, LOQ, LOD, intraday and interday reproducibility, and spike recovery
for all ten synthetic cathinones mixture spiked in urine. It was found that LOQs and
LODs of the ten synthetic cathinones in urine were in the ranges of 0.012 – 9.536 ppm
and 0.004 – 3.147 ppm respectively.
5.1 Recommendations
The following are recommendation for possible future work to extend this study:
•

Applying this analytical method for the detection and quantitative
determination of other synthetic cathinones which have not yet analyzed.

•

Comparing different derivatizing agents such as L-TPC, MCF, and MTPA for
indirect chiral separation of synthetic cathinone compounds.
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•

Using chiral stationary phase column in GC for separation of synthetic
cathinone compounds (direct chiral separation) instead of using CDA (indirect
chiral separation).

•

Comparing different gases in the negative chemical ionization (NCI) source
such as isobutene, ammonia, argon and a mixture of methane and ammonia
(95:5).

•

Comparing negative chemical ionization (NCI) with other ionization
techniques such positive chemical ionization (PCI), and electron impact
ionization (EI) for quantitative determination of synthetic cathinones.

•

Using other biological matrices such as plasma or saliva for the detection and
quantitative determination of synthetic cathinones.

•

Comparing GC-MS with other analytical techniques used for chiral separation
of synthetic cathinones such as HPLC-MS, HPLC-UV, and CE-UV.
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Figure 14: Calibration curves of 2-FEC enantiomers in urine
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Figure 15: Calibration curves of Buphedrone enantiomers in urine
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Figure 16: Calibration curves of 4-MEC enantiomers in urine
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Figure 17: Calibration curves of 3-MethylBP enantiomers in urine
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Figure 18: Calibration curves of 2,4-DMMC enantiomers in urine
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Figure 19: Calibration curves of 4-Methyl- α-ethylaminobutiophenone enantiomers
in urine
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Figure 20: Calibration curves of 3,4-DMEC enantiomers in urine
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Figure 21: Calibration curves of 4-BMC enantiomers in urine
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Figure 22: Calibration curves of Butylone enantiomers in urine
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